what exactly does retatrutide do Retatrutide: The New Triple-Agonist Weight

Health experts are increasingly warning that the reality is much more complicated

Direct cardiac effects remain under investigation

Interpretation of the 2020 American college of cardiologys expert consensus decision path for new treatments to reduce cardiovascular risk in patients with type 2 diabetes: lowering blood sugar should protect the heart

BMI is a number based on weight in relation to height

Safety and tolerability were assessed throughout the study by monitoring adverse events (AEs), clinical laboratory tests, and physical examinations

Clinical Evidence and Impact on Diabetes Multiple randomized controlled trials have documented that GLP1 receptor agonists not only enhance glycemic control but also lead to meaningful weight reduction